These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Altering the regioselectivity of the subterminal fatty acid hydroxylase P450 BM-3 towards gamma- and delta-positions. Dietrich M; Do TA; Schmid RD; Pleiss J; Urlacher VB J Biotechnol; 2009 Jan; 139(1):115-7. PubMed ID: 18984016 [TBL] [Abstract][Full Text] [Related]
5. Structural basis for the properties of two single-site proline mutants of CYP102A1 (P450BM3). Whitehouse CJ; Yang W; Yorke JA; Rowlatt BC; Strong AJ; Blanford CF; Bell SG; Bartlam M; Wong LL; Rao Z Chembiochem; 2010 Dec; 11(18):2549-56. PubMed ID: 21110374 [TBL] [Abstract][Full Text] [Related]
6. Identification of selectivity determinants in CYP monooxygenases by modelling and systematic analysis of sequence and structure. Seifert A; Pleiss J Curr Drug Metab; 2012 Feb; 13(2):197-202. PubMed ID: 22208534 [TBL] [Abstract][Full Text] [Related]
7. Control of the stereo-selectivity of styrene epoxidation by cytochrome P450 BM3 using structure-based mutagenesis. Huang WC; Cullis PM; Raven EL; Roberts GC Metallomics; 2011 Apr; 3(4):410-6. PubMed ID: 21240430 [TBL] [Abstract][Full Text] [Related]
8. Structure, electronic properties and catalytic behaviour of an activity-enhancing CYP102A1 (P450(BM3)) variant. Whitehouse CJ; Yang W; Yorke JA; Tufton HG; Ogilvie LC; Bell SG; Zhou W; Bartlam M; Rao Z; Wong LL Dalton Trans; 2011 Oct; 40(40):10383-96. PubMed ID: 21603690 [TBL] [Abstract][Full Text] [Related]
9. Generation of human metabolites of 7-ethoxycoumarin by bacterial cytochrome P450 BM3. Kim DH; Kim KH; Kim DH; Liu KH; Jung HC; Pan JG; Yun CH Drug Metab Dispos; 2008 Nov; 36(11):2166-70. PubMed ID: 18669587 [TBL] [Abstract][Full Text] [Related]
10. Screening of a minimal enriched P450 BM3 mutant library for hydroxylation of cyclic and acyclic alkanes. Weber E; Seifert A; Antonovici M; Geinitz C; Pleiss J; Urlacher VB Chem Commun (Camb); 2011 Jan; 47(3):944-6. PubMed ID: 21079837 [TBL] [Abstract][Full Text] [Related]
11. A highly active single-mutation variant of P450BM3 (CYP102A1). Whitehouse CJ; Bell SG; Yang W; Yorke JA; Blanford CF; Strong AJ; Morse EJ; Bartlam M; Rao Z; Wong LL Chembiochem; 2009 Jul; 10(10):1654-6. PubMed ID: 19492389 [TBL] [Abstract][Full Text] [Related]
12. Selective hydroxylation of highly branched fatty acids and their derivatives by CYP102A1 from Bacillus megaterium. Budde M; Morr M; Schmid RD; Urlacher VB Chembiochem; 2006 May; 7(5):789-94. PubMed ID: 16566047 [TBL] [Abstract][Full Text] [Related]
13. P450 fingerprinting method for rapid discovery of terpene hydroxylating P450 catalysts with diversified regioselectivity. Zhang K; El Damaty S; Fasan R J Am Chem Soc; 2011 Mar; 133(10):3242-5. PubMed ID: 21341707 [TBL] [Abstract][Full Text] [Related]
14. P450(BM3) (CYP102A1): connecting the dots. Whitehouse CJ; Bell SG; Wong LL Chem Soc Rev; 2012 Feb; 41(3):1218-60. PubMed ID: 22008827 [TBL] [Abstract][Full Text] [Related]
15. A novel semi-biosynthetic route for artemisinin production using engineered substrate-promiscuous P450(BM3). Dietrich JA; Yoshikuni Y; Fisher KJ; Woolard FX; Ockey D; McPhee DJ; Renninger NS; Chang MC; Baker D; Keasling JD ACS Chem Biol; 2009 Apr; 4(4):261-7. PubMed ID: 19271725 [TBL] [Abstract][Full Text] [Related]
16. Evolved CYP102A1 (P450BM3) variants oxidise a range of non-natural substrates and offer new selectivity options. Whitehouse CJ; Bell SG; Tufton HG; Kenny RJ; Ogilvie LC; Wong LL Chem Commun (Camb); 2008 Feb; (8):966-8. PubMed ID: 18283351 [TBL] [Abstract][Full Text] [Related]
17. P450(BM3) on steroids: the Swiss Army knife P450 enzyme just gets better. Wong LL Chembiochem; 2011 Nov; 12(17):2537-9. PubMed ID: 21998091 [TBL] [Abstract][Full Text] [Related]
18. Engineering bacterial cytochrome P450 (P450) BM3 into a prototype with human P450 enzyme activity using indigo formation. Park SH; Kim DH; Kim D; Kim DH; Jung HC; Pan JG; Ahn T; Kim D; Yun CH Drug Metab Dispos; 2010 May; 38(5):732-9. PubMed ID: 20100815 [TBL] [Abstract][Full Text] [Related]
19. Role of residue 87 in substrate selectivity and regioselectivity of drug-metabolizing cytochrome P450 CYP102A1 M11. Vottero E; Rea V; Lastdrager J; Honing M; Vermeulen NP; Commandeur JN J Biol Inorg Chem; 2011 Aug; 16(6):899-912. PubMed ID: 21567268 [TBL] [Abstract][Full Text] [Related]
20. Cloning, expression and characterisation of CYP102A7, a self-sufficient P450 monooxygenase from Bacillus licheniformis. Dietrich M; Eiben S; Asta C; Do TA; Pleiss J; Urlacher VB Appl Microbiol Biotechnol; 2008 Jul; 79(6):931-40. PubMed ID: 18483737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]